Deep Medicine Acquisition Corp. (DMAQ) at a glance
Deep Medicine Acquisition Corp. (DMAQ) is a micro-cap Financial Services company. It trades at $1.35, with a P/E of 213. It does not pay a dividend. Vestovix scores it 41/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Value (20/100).
- Price
- $1.35
- Market cap
- $6.8M
- P/E ratio
- 213.0
- Dividend yield
- None
- Beta
- n/a
- 52-week range
- $0.52 to $8.50
Value
20
Growth
50
Income
40
Safety
66
Momentum
20
Other Financial Services stocks
See allJPM68
JPMorgan Chase & Co.
$349.17+0.74%
1.84% yield
V62
Visa Inc. Class A
$370.72+0.39%
0.81% yield
MA59
Mastercard Incorporated
$566.58+0.52%
0.67% yield
BAC70
Bank of America Corporation
$58.20+1.86%
2.00% yield
MS66
Morgan Stanley
$204.19-0.28%
1.87% yield
HSBC53
HSBC Holdings plc Sponsored ADR
$102.95+0.65%
4.03% yield
GS64
The Goldman Sachs Group, Inc.
$953.27-0.74%
1.60% yield
WFC67
Wells Fargo & Company
$86.84+1.88%
2.15% yield